相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection
Stephanie Planque et al.
AIDS (2010)
An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
Mario Lobigs et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
Gary R. Matyas et al.
AIDS (2009)
Mucosal Vaccine Using CTL Epitope-Pulsed Dendritic Cell Confers Protection for Intracellular Pathogen
Yuichi Ozawa et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Gut-associated lymphoid tissue contains the molecular machinery to support T-cell-dependent and T-cell-independent class switch recombination
F. Barone et al.
MUCOSAL IMMUNOLOGY (2009)
Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination
M. Manrique et al.
MUCOSAL IMMUNOLOGY (2009)
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
Scott G. Hansen et al.
NATURE MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection
Yongjun Guan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Novel humanized murine models for HIV research
Paul W. Denton et al.
Current HIV/AIDS Reports (2009)
DNA-MVA vaccine protection after x4 SHIV challenge in Macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory
Mariana Manrique et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat
Anthony D. Cristillo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation
Anthony D. Cristillo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Freeing vaccine adjuvants from dangerous immunological dogma
Nikolai Petrovsky
EXPERT REVIEW OF VACCINES (2008)
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria
Limin Shang et al.
GASTROENTEROLOGY (2008)
β7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery
Amanda Goodsell et al.
IMMUNOLOGY (2008)
Failure of the Merck HIV vaccine: an uncertain step forward
Merlin L. Robb
LANCET (2008)
Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses
H. Kamijuku et al.
MUCOSAL IMMUNOLOGY (2008)
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
David I. Watkins et al.
NATURE MEDICINE (2008)
Improving defences at the portal of HIV entry: mucosal and innate immunity - A summary report from a global HIV vaccine enterprise working group
Robin J. Shattock et al.
PLOS MEDICINE (2008)
Human immunodeficiency virus type 1 vaccine development: Recent advances in the cytotoxic T-lymphocyte platform Spotty Business
Kimberly A. Schoenly et al.
JOURNAL OF VIROLOGY (2008)
Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection
Amanda J. Chase et al.
JOURNAL OF VIROLOGY (2007)
Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner
Gijs Hardenberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch
Gregory M. Glenn et al.
EXPERT REVIEW OF VACCINES (2007)
Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by Type I and Type II heat-labile enterotoxins
Terry D. Connell
EXPERT REVIEW OF VACCINES (2007)
Randomized placebo controlled phase I/II trial of α-galactosylceramide for the treatment of chronic hepatitis C
Bart J. Veldt et al.
JOURNAL OF HEPATOLOGY (2007)
Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques
G. Koopman et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Acute loss of intestinal CD4(+) T cells is not predictive of simian immunodeficiency virus virulence
Ivona V. Pandrea et al.
JOURNAL OF IMMUNOLOGY (2007)
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
Shin-ichiro Fujii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa
IM Belyakov et al.
BLOOD (2006)
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract
FW van Ginkel et al.
INFECTION AND IMMUNITY (2005)
Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate
R Pal et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2005)
The role of adjuvants in the development of mucosal vaccines
M Vajdy et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
Innate immunity in experimental SIV infection and vaccination
RKS Ahmed et al.
MOLECULAR IMMUNOLOGY (2005)
Mucosa-associated lymphoid tissues in the aerodigestive tract: Their shared and divergent traits and their importance to the orchestration of the mucosal immune system
J Kunisawa et al.
CURRENT MOLECULAR MEDICINE (2005)
Mucosal adjuvants
L Stevceva et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates
FMN Bertley et al.
JOURNAL OF IMMUNOLOGY (2004)
Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus
Y Asahi-Ozaki et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
JM Brenchley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
SW Wang et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses
DG Silva et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1Ba-L
R Pal et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency
R Pal et al.
JOURNAL OF VIROLOGY (2002)
Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization
CP Bradney et al.
JOURNAL OF VIROLOGY (2002)
Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization
HF Staats et al.
JOURNAL OF IMMUNOLOGY (2001)
HIV type 1-specific IgG2 antibodies: Markers of helper T cell type 1 response and prognostic marker of long-term nonprogression
N Ngo-Giang-Huong et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1
O Scharf et al.
JOURNAL OF VIROLOGY (2001)
Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues
FW van Ginkel et al.
JOURNAL OF IMMUNOLOGY (2000)
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells
C Devito et al.
JOURNAL OF IMMUNOLOGY (2000)